Synnovation Therapeutics

Accent Therapeutics

This biopharmaceutical company develops small molecule precision therapies for patients with various types of cancer.

Scorpion

This company develops small molecule precision oncology therapies for patients with various cancers.

Flindr Therapeutics

This company develops small molecule inhibitors for the precision treatment of cancer patients with specific tumor and host factors.

Nuvectis Pharma

This biopharmaceutical company develops precision medicines and targeted small molecule therapeutics for patients with advanced cancers and other serious conditions.

Treeline Biosciences

This company develops small molecules and targeted therapies for patients with oncology, immunology and neurology diseases using computational and experimental discovery tools.

Rapport Therapeutics

This company develops small molecule precision medicines for patients suffering from central nervous system disorders.

Chromacure

This company develops small molecule therapeutics for oncology patients to address unmet clinical needs in cancer treatment.

Scorpion Therapeutics

This clinical-stage company develops small-molecule drugs and targeted therapies for patients with various forms of cancer.